[ad_1] ZURICH (Reuters) – Baloxavir marboxil, an influenza drug, has significantly relieved patients who are extremely vulnerable to serious complications, a top-of-the-line clinical trial said Thursday, according to Swiss drug maker Roche. …
Read More »